Aspetar Clinical Guidelines

Aspetar Clinical Guidelines

General information

Aspetar’s Clinical Guideline and Pathway Committee provides oversight to the Aspetar Clinical Guidelines process (development and implementation).
Clinical Guideline Development Groups (GDGs) with subject matter expertise develop Aspetar’s Clinical Guidelines through a rigorous process of evidence synthesis and peer review.

The Aspetar Clinical Guidelines and Pathways Committee was established in 2020 and aims to provide oversight to the development of clinical guidelines and pathways in sports medicine that are evidence-based, up-to-date, relevant, free from industry influence, and appropriately implemented.

MEMBERS TITLE ORGANIZATION
Paul Dijkstra (Chairperson) Sports Medicine Physician/ Director of Medical Education Medical education
Sofie Eline Nelis (Deputy chairperson) Lead Medical Education Specialist Medical education
Raouf Rekik NSMP Club and Federation Doctor NSMP Clubs and Federations
Celeste Geertsema Sports Medicine Physician Sports Medicine Department
Michael Saretsky Senior Physiotherapist Rehabilitation Department
Vasileios Korakakis Senior Physiotherapist Rehabilitation Department
Sean McCrudden Nursing Supervisor – Education Coordinator Nursing Department
Samson Nadarajan Revenue Cycle Analyst Patient Accounts Department
Syed Sajid Ahmed Head of Quality Management Planning and Performance Department

 

  • Aspetar Clinical Guideline - Safe return to sport during the COVID-19 pandemic Version 2.0

     

    Version 2.0  Date: March 2021

     

    PDF file: Download PDF

 

 

 

Qatar National Physical Activity Guidelines - 2nd Edition
Version 2.0

 

 

  • Aspetar Post-COVID19 Health Evaluation Algorithm  download pdf
  • A Framework for return to training after COVID-19  download pdf
  • Aspetar Club Federation Doctor Initial Medical Questionnaire  download pdf
PDF Files
Qatar National Physical Activity Guidelines - 2nd Edition
Ramadan Fasting and Exercise for Healthy Individuals
Safe return to sport during the COVID-19